Sophie Patterson1, Angela Kaida1, Paul Nguyen1, Sabina Dobrer1, Gina Ogilvie1, Robert Hogg1, Thomas Kerr1, Julio Montaner1, Evan Wood1, M-J Milloy1. 1. Faculty of Health Sciences (Patterson, Kaida, Hogg), Simon Fraser University, Burnaby; British Columbia Centre for Excellence in HIV/AIDS (Patterson, Nguyen, Dobrer, Hogg, Kerr, Montaner, Wood, Milloy), St. Paul's Hospital; BC Women's Hospital and Health Centre (Ogilvie); Faculty of Medicine, University of British Columbia, Vancouver, BC.
Abstract
BACKGROUND: In October 2012, the Canadian Supreme Court ruled that people living with HIV must disclose their HIV status before sex that poses a "realistic possibility" of HIV transmission, clarifying that in circumstances where condom-protected penile-vaginal intercourse occurred with a low viral load (< 1500 copies/mL), the realistic possibility of transmission would be negated. We estimated the proportion of people living with HIV who use injection drugs who would face a legal obligation to disclose under these circumstances. METHODS: : We used cross-sectional survey data from a cohort of people living with HIV who inject drugs. Participants interviewed since October 2012 who self-reported recent penile-vaginal intercourse were included. Participants self-reporting 100% condom use with a viral load consistently < 1500 copies/mL were assumed to have no legal obligation to disclose. Logistic regression identified factors associated with facing a legal obligation to disclose. RESULTS: We included 176 participants, 44% of whom were women: 94% had a low viral load, and 60% self-reported 100% condom use. If condom use and low viral load were required to negate the realistic possibility of transmission, 44% would face a legal obligation to disclose. Factors associated with facing a legal obligation to disclose were female sex (adjusted odds ratio [OR] 2.19, 95% confidence interval [CI] 1.13-4.24), having 1 recent sexual partner (v. > 1) (adjusted OR 2.68, 95% CI 1.24-5.78) and self-reporting a stable relationship (adjusted OR 2.00, 95% CI 1.03-3.91). INTERPRETATION: Almost half the participants in our analytic sample would face a legal obligation to disclose to sexual partners under these circumstances (with an increased burden among women), adding further risk of criminalization within this marginalized and vulnerable community.
BACKGROUND: In October 2012, the Canadian Supreme Court ruled that people living with HIV must disclose their HIV status before sex that poses a "realistic possibility" of HIV transmission, clarifying that in circumstances where condom-protected penile-vaginal intercourse occurred with a low viral load (< 1500 copies/mL), the realistic possibility of transmission would be negated. We estimated the proportion of people living with HIV who use injection drugs who would face a legal obligation to disclose under these circumstances. METHODS: : We used cross-sectional survey data from a cohort of people living with HIV who inject drugs. Participants interviewed since October 2012 who self-reported recent penile-vaginal intercourse were included. Participants self-reporting 100% condom use with a viral load consistently < 1500 copies/mL were assumed to have no legal obligation to disclose. Logistic regression identified factors associated with facing a legal obligation to disclose. RESULTS: We included 176 participants, 44% of whom were women: 94% had a low viral load, and 60% self-reported 100% condom use. If condom use and low viral load were required to negate the realistic possibility of transmission, 44% would face a legal obligation to disclose. Factors associated with facing a legal obligation to disclose were female sex (adjusted odds ratio [OR] 2.19, 95% confidence interval [CI] 1.13-4.24), having 1 recent sexual partner (v. > 1) (adjusted OR 2.68, 95% CI 1.24-5.78) and self-reporting a stable relationship (adjusted OR 2.00, 95% CI 1.03-3.91). INTERPRETATION: Almost half the participants in our analytic sample would face a legal obligation to disclose to sexual partners under these circumstances (with an increased burden among women), adding further risk of criminalization within this marginalized and vulnerable community.
Authors: D M Patrick; S A Strathdee; C P Archibald; M Ofner; K J Craib; P G Cornelisse; M T Schechter; M L Rekart; M V O'Shaughnessy Journal: Int J STD AIDS Date: 1997-07 Impact factor: 1.359
Authors: A M Cescon; C Cooper; K Chan; A K Palmer; M B Klein; N Machouf; M R Loutfy; J Raboud; A Rachlis; E Ding; V D Lima; J S G Montaner; S B Rourke; M Smieja; C Tsoukas; R S Hogg Journal: HIV Med Date: 2010-11-08 Impact factor: 3.180
Authors: Lianping Ti; M-J Milloy; Kate Shannon; Annick Simo; Robert S Hogg; Sylvia Guillemi; Julio Montaner; Thomas Kerr; Evan Wood Journal: Sex Transm Infect Date: 2014-02-12 Impact factor: 3.519
Authors: Roger D Kouyos; Barbara Hasse; Alexandra Calmy; Matthias Cavassini; Hansjakob Furrer; Marcel Stöckle; Pietro L Vernazza; Enos Bernasconi; Rainer Weber; Huldrych F Günthard; V Aubert; M Battegay; E Bernasconi; J Böni; H C Bucher; C Burton-Jeangros; A Calmy; M Cavassini; G Dollenmaier; M Egger; L Elzi; J Fehr; J Fellay; H Furrer; C A Fux; M Gorgievski; H Günthard; D Haerry; B Hasse; H H Hirsch; M Hoffmann; I Hösli; C Kahlert; L Kaiser; O Keiser; T Klimkait; R Kouyos; H Kovari; B Ledergerber; G Martinetti; B Martinez de Tejada; K Metzner; N Müller; D Nadal; D Nicca; G Pantaleo; A Rauch; S Regenass; M Rickenbach; C Rudin; F Schöni-Affolter; P Schmid; J Schüpbach; R Speck; P Tarr; A Trkola; P Vernazza; R Weber; S Yerly Journal: Open Forum Infect Dis Date: 2015-06-03 Impact factor: 3.835
Authors: Sophie Patterson; Angela Kaida; Gina Ogilvie; Robert Hogg; Valerie Nicholson; Sabina Dobrer; Thomas Kerr; Jean Shoveller; Julio Montaner; M-J Milloy Journal: Int J Drug Policy Date: 2017-03-28
Authors: Sophie Patterson; Valerie Nicholson; Rebecca Gormley; Allison Carter; Carmen H Logie; Kalysha Closson; Erin Ding; Jason Trigg; Jenny Li; Robert Hogg; Alexandra de Pokomandy; Mona Loutfy; Angela Kaida Journal: Womens Health (Lond) Date: 2022 Jan-Dec